Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1267

1.

Efficacy and safety of saxagliptin in combination with insulin in Japanese patients with type 2 diabetes mellitus: a 16-week double-blind randomized controlled trial with a 36-week open-label extension.

Kadowaki T, Muto S, Ouchi Y, Shimazaki R, Seino Y.

Expert Opin Pharmacother. 2017 Sep 13. doi: 10.1080/14656566.2017.1379990. [Epub ahead of print]

PMID:
28901796
2.
3.

Alcohol consumption and bladder cancer risk with or without the flushing response: The Japan Public Health Center-based Prospective Study.

Masaoka H, Matsuo K, Sawada N, Yamaji T, Goto A, Shimazu T, Iwasaki M, Inoue M, Eto M, Tsugane S; Japan Public Health Center-based Prospective Study Group.

Int J Cancer. 2017 Sep 5. doi: 10.1002/ijc.31028. [Epub ahead of print]

PMID:
28875523
4.

Istradefylline improves daytime sleepiness in patients with Parkinson's disease: An open-label, 3-month study.

Suzuki K, Miyamoto M, Miyamoto T, Uchiyama T, Watanabe Y, Suzuki S, Kadowaki T, Fujita H, Matsubara T, Sakuramoto H, Hirata K.

J Neurol Sci. 2017 Sep 15;380:230-233. doi: 10.1016/j.jns.2017.07.045. Epub 2017 Jul 29.

PMID:
28870576
5.

Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease.

Zhao W, Rasheed A, Tikkanen E, Lee JJ, Butterworth AS, Howson JMM, Assimes TL, Chowdhury R, Orho-Melander M, Damrauer S, Small A, Asma S, Imamura M, Yamauch T, Chambers JC, Chen P, Sapkota BR, Shah N, Jabeen S, Surendran P, Lu Y, Zhang W, Imran A, Abbas S, Majeed F, Trindade K, Qamar N, Mallick NH, Yaqoob Z, Saghir T, Rizvi SNH, Memon A, Rasheed SZ, Memon FU, Mehmood K, Ahmed N, Qureshi IH, Tanveer-Us-Salam, Iqbal W, Malik U, Mehra N, Kuo JZ, Sheu WH, Guo X, Hsiung CA, Juang JJ, Taylor KD, Hung YJ, Lee WJ, Quertermous T, Lee IT, Hsu CC, Bottinger EP, Ralhan S, Teo YY, Wang TD, Alam DS, Di Angelantonio E, Epstein S, Nielsen SF, Nordestgaard BG, Tybjaerg-Hansen A, Young R; CHD Exome+ Consortium, Benn M, Frikke-Schmidt R, Kamstrup PR; EPIC-CVD Consortium; EPIC-Interact Consortium; Michigan Biobank, Jukema JW, Sattar N, Smit R, Chung RH, Liang KW, Anand S, Sanghera DK, Ripatti S, Loos RJF, Kooner JS, Tai ES, Rotter JI, Chen YI, Frossard P, Maeda S, Kadowaki T, Reilly M, Pare G, Melander O, Salomaa V, Rader DJ, Danesh J, Voight BF, Saleheen D.

Nat Genet. 2017 Sep 4. doi: 10.1038/ng.3943. [Epub ahead of print]

PMID:
28869590
6.

Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease: a multicentre cross-sectional study.

Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Sakakibara R, Shimo Y, Hattori N, Kuwabara S, Yamamoto T, Kaji Y, Hirano S, Kadowaki T, Hirata K; Kanto NMPD investigators.

J Neurol Neurosurg Psychiatry. 2017 Aug 28. pii: jnnp-2017-316136. doi: 10.1136/jnnp-2017-316136. [Epub ahead of print]

7.

Dietary magnesium intake and risk of incident coronary heart disease in men: A prospective cohort study.

Kokubo Y, Saito I, Iso H, Yamagishi K, Yatsuya H, Ishihara J, Maruyama K, Inoue M, Sawada N, Tsugane S; JPHC Study Group.

Clin Nutr. 2017 Aug 12. pii: S0261-5614(17)30274-1. doi: 10.1016/j.clnu.2017.08.006. [Epub ahead of print]

PMID:
28843443
8.

Characterizing restless legs syndrome and leg motor restlessness in patients with Parkinson's disease: A multicenter case-controlled study.

Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Sakakibara R, Shimo Y, Hattori N, Kuwabara S, Yamamoto T, Kaji Y, Hirano S, Numao A, Hirata K; Kanto NMPD investigators.

Parkinsonism Relat Disord. 2017 Aug 14. pii: S1353-8020(17)30288-2. doi: 10.1016/j.parkreldis.2017.08.007. [Epub ahead of print]

PMID:
28827009
9.

NFIA co-localizes with PPARĪ³ and transcriptionally controls the brown fat gene program.

Hiraike Y, Waki H, Yu J, Nakamura M, Miyake K, Nagano G, Nakaki R, Suzuki K, Kobayashi H, Yamamoto S, Sun W, Aoyama T, Hirota Y, Ohno H, Oki K, Yoneda M, White AP, Tseng YH, Cypess AM, Larsen TJ, Jespersen NZ, Scheele C, Tsutsumi S, Aburatani H, Yamauchi T, Kadowaki T.

Nat Cell Biol. 2017 Sep;19(9):1081-1092. doi: 10.1038/ncb3590. Epub 2017 Aug 14.

PMID:
28812581
10.

Rab44, a novel large Rab GTPase, negatively regulates osteoclast differentiation by modulating intracellular calcium levels followed by NFATc1 activation.

Yamaguchi Y, Sakai E, Okamoto K, Kajiya H, Okabe K, Naito M, Kadowaki T, Tsukuba T.

Cell Mol Life Sci. 2017 Aug 8. doi: 10.1007/s00018-017-2607-9. [Epub ahead of print]

PMID:
28791425
11.

Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, placebo-controlled, parallel-group comparative study.

Kadowaki T, Inagaki N, Kondo K, Nishimura K, Kaneko G, Maruyama N, Nakanishi N, Gouda M, Iijima H, Watanabe Y.

Diabetes Obes Metab. 2017 Aug 8. doi: 10.1111/dom.13079. [Epub ahead of print]

PMID:
28786530
12.

CDK5 Regulatory Subunit-Associated Protein 1-like 1 Negatively Regulates Adipocyte Differentiation through Activation of Wnt Signaling Pathway.

Take K, Waki H, Sun W, Wada T, Yu J, Nakamura M, Aoyama T, Yamauchi T, Kadowaki T.

Sci Rep. 2017 Aug 4;7(1):7326. doi: 10.1038/s41598-017-06469-5.

13.

Structural Basis and Genotype-phenotype Correlations of INSR Mutations Causing Severe Insulin Resistance.

Hosoe J, Kadowaki H, Miya F, Aizu K, Kawamura T, Miyata I, Satomura K, Ito T, Hara K, Tanaka M, Ishiura H, Tsuji S, Suzuki K, Takakura M, Boroevich KA, Tsunoda T, Yamauchi T, Shojima N, Kadowaki T.

Diabetes. 2017 Aug 1. pii: db170301. doi: 10.2337/db17-0301. [Epub ahead of print]

PMID:
28765322
14.

Echinomycin inhibits adipogenesis in 3T3-L1 cells in a HIF-independent manner.

Yamaguchi J, Tanaka T, Saito H, Nomura S, Aburatani H, Waki H, Kadowaki T, Nangaku M.

Sci Rep. 2017 Jul 26;7(1):6516. doi: 10.1038/s41598-017-06761-4.

15.

Efficacy and safety of teneligliptin add-on to insulin monotherapy in Japanese patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled trial with an open-label period.

Kadowaki T, Kondo K, Sasaki N, Miyayama K, Yokota S, Terata R, Gouda M.

Expert Opin Pharmacother. 2017 Sep;18(13):1291-1300. doi: 10.1080/14656566.2017.1359259. Epub 2017 Aug 10.

PMID:
28741385
16.

Smoking and alcohol and subsequent risk of myelodysplastic syndromes in Japan: the Japan Public Health Centre-based Prospective Study.

Ugai T, Matsuo K, Sawada N, Iwasaki M, Yamaji T, Shimazu T, Sasazuki S, Inoue M, Kanda Y, Tsugane S; Japan Public Health Centre-based Prospective Study Group.

Br J Haematol. 2017 Sep;178(5):747-755. doi: 10.1111/bjh.14749. Epub 2017 Jul 17.

PMID:
28714213
17.

Role of insulin receptor substrates in the progression of hepatocellular carcinoma.

Sakurai Y, Kubota N, Takamoto I, Obata A, Iwamoto M, Hayashi T, Aihara M, Kubota T, Nishihara H, Kadowaki T.

Sci Rep. 2017 Jul 14;7(1):5387. doi: 10.1038/s41598-017-03299-3.

18.

Dose-Response Relationship Between Severe Hypercholesterolemia and Body Mass Index in Healthy Young Adults.

Yamada T, Yanagimoto S, Kadowaki T.

Mayo Clin Proc. 2017 Jul;92(7):1167-1168. doi: 10.1016/j.mayocp.2017.05.007. No abstract available.

PMID:
28688471
19.

Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target.

Marangoni RG, Masui Y, Fang F, Korman B, Lord G, Lee J, Lakota K, Wei J, Scherer PE, Otvos L, Yamauchi T, Kubota N, Kadowaki T, Asano Y, Sato S, Tourtellotte WG, Varga J.

Sci Rep. 2017 Jun 30;7(1):4397. doi: 10.1038/s41598-017-04162-1.

20.

[[CASE OF TUBERCULOSIS COMPLICATIONS DURING PREGNANCY LEADING TO AN INFECTION OUTBREAK].]

Nishikawa E, Yano S, Tada M, Iwamoto S, Kadowaki T, Kimura M, Kobayashi K, Ikeda T.

Kekkaku. 2016 May;91(5):515-518. Japanese.

PMID:
28661593

Supplemental Content

Loading ...
Support Center